Projects




Uncovering vulnerability of the myelin-axon unit in Alzheimer's disease


In Alzheimer’s disease (AD), myelin–axon interface, axon–glial signaling, paranodal architecture and amyloid-β aggregation are altered, implicating myelin–axon disruption in disease progression.




Deciphering molecular mechanisms of axonal pathology in Alzheimer’s’ disease


Integration of subcellular proximity labeling proteomics in human postmortem brains, and molecular manipulation in human iPSC-derived AD model and AD-model mice, we aim to to uncover mechanisms of axonal pathology in Alzheimer’s disease




Decode competing endogenous RNA (ceRNA) regulation in Alzheimer's disease


Long non-coding RNA, microRNA and mRNA regulation network and hierachy




Generation and analysis of SETD1A-deficient human neurons in schizophrenia


Protein targets of Setd1a strongly correlate to schizophrenia Genome-Wide Association Study signals

Share

Tools
Translate to